NVAX
Income statement / Annual
Last year (2024), Novavax, Inc.'s total revenue was $682.16 M,
an increase of 22.61% from the previous year.
In 2024, Novavax, Inc.'s net income was -$187.50 M.
See Novavax, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$682.16 M |
$556.38 M |
$1.60 B |
$1.15 B |
$475.60 M |
$18.66 M |
$34.29 M |
$31.18 M |
$15.35 M |
$36.25 M |
| Cost of Revenue |
$202.74 M
|
$343.77 M
|
$902.64 M
|
$12.66 M
|
$747.03 M
|
$113.84 M
|
$0.00
|
$0.00
|
$237.94 M
|
$162.64 M
|
| Gross Profit |
$479.42 M
|
$212.61 M
|
$696.31 M
|
$1.13 B
|
-$271.43 M
|
-$95.18 M
|
$34.29 M
|
$31.18 M
|
-$222.59 M
|
-$126.39 M
|
| Gross Profit Ratio |
0.7
|
0.38
|
0.44
|
0.99
|
-0.57
|
-5.1
|
1
|
1
|
-14.5
|
-3.49
|
| Research and Development Expenses |
$391.17 M
|
$737.50 M
|
$1.24 B
|
$2.53 B
|
$747.03 M
|
$113.84 M
|
$173.80 M
|
$168.44 M
|
$237.94 M
|
$162.64 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$488.69 M
|
$298.36 M
|
$145.29 M
|
$34.42 M
|
$34.41 M
|
$34.45 M
|
$46.53 M
|
$30.84 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$337.19 M
|
$468.95 M
|
$488.69 M
|
$298.36 M
|
$145.29 M
|
$34.42 M
|
$34.41 M
|
$34.45 M
|
$46.53 M
|
$30.84 M
|
| Other Expenses |
$0.00
|
-$427.32 M
|
-$382.92 M
|
-$8.20 M
|
$12.59 M
|
-$13,000.00
|
$108,000.00
|
$67,000.00
|
-$31,000.00
|
-$120,000.00
|
| Operating Expenses |
$728.35 M
|
$779.13 M
|
$1.34 B
|
$2.83 B
|
$892.32 M
|
$148.26 M
|
$208.21 M
|
$202.89 M
|
$284.47 M
|
$193.49 M
|
| Cost And Expenses |
$931.09 M
|
$1.12 B
|
$2.24 B
|
$2.83 B
|
$892.32 M
|
$148.26 M
|
$208.21 M
|
$202.89 M
|
$284.47 M
|
$193.49 M
|
| Interest Income |
$0.00
|
$0.00
|
$19.88 M
|
$1.36 M
|
$1.01 M
|
$1.51 M
|
$0.00
|
$1.95 M
|
$0.00
|
$660,000.00
|
| Interest Expense |
$20.08 M
|
$14.42 M
|
$19.88 M
|
$21.13 M
|
$15.15 M
|
$12.19 M
|
$12.19 M
|
$14.07 M
|
$12.97 M
|
$241,000.00
|
| Depreciation & Amortization |
$48.50 M
|
$41.23 M
|
$29.05 M
|
$12.66 M
|
$4.89 M
|
$5.80 M
|
$8.16 M
|
$9.82 M
|
$8.51 M
|
$5.98 M
|
| EBITDA |
-$108.04 M |
-$487.39 M |
-$604.71 M |
-$1.68 B |
-$398.23 M |
-$114.83 M |
-$162.98 M |
-$159.88 M |
-$258.50 M |
-$150.71 M |
| EBITDA Ratio |
-0.16
|
-0.88
|
-0.4
|
-1.47
|
-0.88
|
-7.43
|
-5.07
|
-5.51
|
-17.53
|
-4.34
|
| Operating Income Ratio |
-0.36
|
-1.02
|
-0.4
|
-1.47
|
-0.88
|
-6.46
|
-5.07
|
-5.51
|
-17.53
|
-4.34
|
| Total Other Income/Expenses Net |
$72.32 M
|
$23.48 M
|
-$8.91 M
|
-$27.96 M
|
-$1.54 M
|
-$12.11 M
|
-$10.83 M
|
-$12.06 M
|
-$10.85 M
|
$299,000.00
|
| Income Before Tax |
-$176.62 M
|
-$543.03 M
|
-$653.65 M
|
-$1.71 B
|
-$418.26 M
|
-$132.69 M
|
-$184.75 M
|
-$183.77 M
|
-$279.97 M
|
-$156.94 M
|
| Income Before Tax Ratio |
-0.26
|
-0.98
|
-0.41
|
-1.5
|
-0.88
|
-7.11
|
-5.39
|
-5.89
|
-18.24
|
-4.33
|
| Income Tax Expense |
$10.88 M
|
$2.03 M
|
$4.29 M
|
$29.22 M
|
$9.25 M
|
-$2.59 M
|
$1.36 M
|
$2.31 M
|
$2.32 M
|
-$6.40 M
|
| Net Income |
-$187.50 M
|
-$545.06 M
|
-$657.94 M
|
-$1.74 B
|
-$427.51 M
|
-$130.10 M
|
-$184.75 M
|
-$183.77 M
|
-$279.97 M
|
-$156.94 M
|
| Net Income Ratio |
-0.27
|
-0.98
|
-0.41
|
-1.52
|
-0.9
|
-6.97
|
-5.39
|
-5.89
|
-18.24
|
-4.33
|
| EPS |
-1.23 |
-5.41 |
-8.42 |
-23.44 |
-7.43 |
-5.4 |
-9.99 |
-12.56 |
-20.68 |
-11.97 |
| EPS Diluted |
-1.23 |
-5.41 |
-8.42 |
-23.44 |
-7.43 |
-5.4 |
-9.99 |
-12.56 |
-20.68 |
-11.97 |
| Weighted Average Shares Out |
$152.19 M
|
$100.77 M
|
$78.18 M
|
$74.40 M
|
$57.55 M
|
$24.10 M
|
$18.49 M
|
$14.63 M
|
$13.54 M
|
$13.11 M
|
| Weighted Average Shares Out Diluted |
$152.19 M
|
$100.77 M
|
$78.18 M
|
$74.40 M
|
$57.55 M
|
$24.10 M
|
$18.49 M
|
$14.63 M
|
$13.54 M
|
$13.11 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
